Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study

ConclusionsA basal –bolus regimen including Gla-300 OD was associated with improvements in HbA1c and treatment satisfaction in people with uncontrolled T1DM previously receiving basal –bolus insulin including a basal insulin BID analogue.Trial RegistrationEudraCT number: 2015-001186-46.

http://link.springer.com/10.1007/s13300-019-00749-1

Source: Diabetes Therapy - January 9, 2020 Category: Endocrinology Source Type: research